Wednesday, September 16, 2026Latest filing Sep 14, 2026

Daniel Meuser Periodic Transaction Report

Filed Apr 3, 2026 · House Clerk · 1 transaction

U.S. Representative · R · PA-09 · All trades by Daniel Meuser

On April 3, 2026, Rep. Daniel Meuser (R-PA-09) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Feb 25, 2026.

The filing covers 1 ticker, including $NVDA.

Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 37 days.

1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.

Source document: House Clerk filing 20034158

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Daniel Meuser · Sold $NVDA · Feb 25 · $1K–$15K

0.29LOW
Disclosure speedx 0.250.10
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.62

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Daniel Meuser

Get an email the moment Daniel Meuser files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
37d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Feb 25, 2026NVDANVIDIA Corporation - Common StocksellSpouse$1K–$15K37d

Other recent filings by Daniel Meuser

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →